Enzyme Set for use with Fluorescence Differential Display Kit Enzyme Set-FDD Code No. R025A Description: Shipping at -20°C Stored at -20°C This set includes enzymes required to perform Differential Display method in conjunction use with Takara's Fluorescence Differential Display Kit Fluorescein version (Cat.#6625) Rhodamine version (Cat.#6626). Component: 1. AMV Reverse Transcriptase XL* (5 U/µl) 30 µlX1 2. RNase Inhibitor (40 U/µl) 15 µlX1 3. RNase Free dH2O 1 mlX1 4. TaKaRa LA Taq™ (5 U/µl) 25 µlX3 5. 10 x RNA PCR Buffer 100 µlX1 6. 10 x LA PCR Buffer II (Mg2+ free) 1 mlX2 7. dNTP Mixture (10 mM) 300 µlX1 8. MgCl2 (25 mM) 1.2 mlX1 9. DNase I (RNase-free) (5 U/µl) 10 µlX1 *Manufactured by Life Sciences, Inc. Storage: ●製品説明明 Fluorescence Differential Display Kitを用いたDD法をおこなうためのAMV逆転写酵素と、TaKaRa LA TaqTMおよびその他の試薬のセットです。 ●包装単位１set ●内容 1. AMV Reverse Transcriptase XL* (5 U/µl) 30 µl×1 2. RNase Inhibitor (40 U/µl) 15 µl×1 3. RNase Free dH2O 1 ml×1 4. TaKaRa LA Taq™ (5 U/µl) 25 µl×3 5. 10 x RNA PCR Buffer 100 µl×1 6. 10 x LA PCR Buffer II (Mg2+ free) 1 ml×2 7. dNTP Mixture (10 mM) 300 µl×1 8. MgCl2 (25 mM) 1.2 ml×1 9. DNase I (RNase-free) (5 U/µl) 10 µl×1 ★ Anvian Myeloblastosis Virus 由来 Life Sciences社で製造されたものです。 ●保存 − 20 ℃ ●保存 −2 0℃ - 20°C Note For research use only. Not for use in diagnostic or therapeutic procedures. Produced by TAKARA BIO TECHNOLOGY ( DALIAN ) CO.,LTD. U. S. Patent 5,436,149 for LA Technology is owned by TAKARA BIO INC. 注意 ●注本製品は研究用試薬です。ヒト、動物への医療、臨床診断には使用しないようご注意ください。また、食品、化粧品、家庭用品等として使用しないでください。 NOTICE TO PURCHASE : LIMITED LICENSE A license under the foreign counterparts U.S. Patents Nos. 4,683,202, 4,683,195 and 4,965,188, owned by F.Hoffmann-La Roche Ltd., for use in research and development, has an up-front fee component and a running-royalty component. The purchase price of this product includes limited, nontransferable rights under the running-royalty component to use only this amount of the product to practice the polymerase chain reaction (PCR) and related processes described in said patents where such processes are covered by patents solely for the research and development activities of the purchaser when this product is used in conjunction with a thermal cycler whose use is covered by the up-front fee component. Rights to the upfront fee component must be obtained by the end user in order to have a complete license to use this product in the PCR process where the process is covered by patents. These rights under the up-front fee component may be purchased from Applied Biosystems or obtained by purchasing an authorized thermal cycler. No right to perform or offer commercial services of any kind using PCR, where the process is covered by patents, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is hereby granted by implication or estoppel. Further information on purchasing licenses to practice the PCR process where the process is covered by patents may be obtained by contacting the Director of Licensing at Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404 or the Licensing Department, Roche Molecular Systems, Inc., 1145 Atlantic Avenue, Alameda, California 94501. V2005.06 ･･････････････････････････････････････････････････････････････････････････････････････････････････････製品についての技術的なお問い合わせ先 TaKaRaテクニカルサポートライン Tel 077-543-6116 Fax 077-543-1977